Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of GLP-1 Receptors Agonist Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients

NCT02274740 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT02274740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02274740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of GLP-1 Receptors Agonist Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2015
Completion date
August 31, 2015
Enrollment
2 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

type ii diabetes mellitus